Tsingke Highlights AI-Driven CLDN18.2 Antibody Discovery at AIS 2026
MONTPELLIER, France, July 8, 2026 /PRNewswire/ -- Tsingke, a provider of integrated life science research solutions, participated in the Antibody Industrial Symposium (AIS) 2026, one of Europe's leading conferences dedicated to therapeutic...
Tsingke Gene Leads a Delivery Revolution with "Calendar Day Delivery"
BEIJING, April 23, 2025 /PRNewswire/ -- In March 2025, Tsingke pioneered the industry's first full-range "Calendar Day Delivery" model, redefining standards for gene synthesis services through a comprehensive suite of offerings such as Tsynth™Gene...